Mahrukh Rehan

NVAX

IMARA Inc. (IMRA) is increasing by 8% in premarket – Learn more!

IMARA Inc. (IMRA) experienced an increase of 8% in the premarket after the clearance of tovinontrine application by the FDA. However, the last trading session concluded at $1.5 with a decrease of 4.46%. Clearance of tovinontrine application – What’s New? On 25th January 2022, IMRA announced that FDA has approved the application for tovinontrine drug. …

IMARA Inc. (IMRA) is increasing by 8% in premarket – Learn more! Read More »

AMD Stock

SAB Biotherapeutics, Inc. (SABS) Stock Undergoes Minor Volatility – Here’s why?

SAB Biotherapeutics, Inc. (SABS) remained unchanged in the premarket after the company updated the Positive Phase 2 Virology Data. However, the last trading session closed at $5.48 with a decrease of 5.84%. Positive Phase 2 Virology Data – What’s this? SABS announced the positive phase 2 virology data on 24th January 2022. According to the …

SAB Biotherapeutics, Inc. (SABS) Stock Undergoes Minor Volatility – Here’s why? Read More »

ALPP

Alpine 4 Holdings, Inc. (ALPP) stock has increased to 2.96% in premarket – Learn why?

Alpine 4 Holdings, Inc. (ALPP) has seen a push of 2.96% in the premarket following the announcement that one of the company’s subsidiaries has secured $1.2 Million of new purchase orders. However, the last trading session closed at $1.69 with an increase of 10.46%. $1.2 Million of new purchase orders – What’s going on? On …

Alpine 4 Holdings, Inc. (ALPP) stock has increased to 2.96% in premarket – Learn why? Read More »

NVAX

Marker Therapeutics Inc (MRKR) stock is rising in premarket – What’s going on?

Marker Therapeutics Inc (MRKR) has seen a boost of 13.15% in premarket today following the announcement that the company received FDA Orphan Drug Designation. However, the last trading session concluded at $0.8396 with a decrease of 2.69%. FDA Orphan Drug Designation – All About it MRKR announced on 19th January 2022 that MT-601 has been …

Marker Therapeutics Inc (MRKR) stock is rising in premarket – What’s going on? Read More »